Clinical trial
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
NCT04113109
Study timeline
Study start (actual)2019-11-01Date precision: day
Registry last updated2026-08-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Interventions
LCZ 696DRUG
IcatibantDRUG · verified · RxNorm: icatibant
placeboDRUG
IohexolDRUG · verified · RxNorm: iohexol
Sponsors & collaborators
Vanderbilt University Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04113109 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.